Abi Pinchbeck, Editor, Cell and Gene Therapy Insights, speaks to Adam Fung, a CMC and quality strategy and operations leader in cell and gene therapy with over 15 years of experience. The discussion emphasizes the importance of automation, innovation, and strategic planning in shaping the future of biopharma analytics, particularly in the development of CAR-T cell therapies.
